Actively Recruiting
French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)
Led by University Hospital, Montpellier · Updated on 2025-07-10
37
Participants Needed
1
Research Sites
243 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The overall objective of this GUIDE.MRD consortium is to confirm that ctDNA detected after curative intended treatment for PDAC is a marker of residual disease and for risk-of-recurrence, and applicable in clinical practice. Primary objective To confirm that ctDNA analyses performed after PDAC treatment can identify patients with a high risk-of-recurrence. Specifically, the investigators want to determine the association between disease-free survival (DFS) and ctDNA detection status after 1. curative-intended surgery and 2. adjuvant chemotherapy. FRENCH.MRD.PDAC is the French study of the european GUIDE.MRD project
CONDITIONS
Official Title
French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with pancreatic ductal adenocarcinoma as determined by the multidisciplinary tumor board.
- Age 18 years or older.
- Scheduled for surgery with curative intent.
You will not qualify if you...
- Having hereditary pancreatic cancer.
- Presence of confirmed distant metastases.
- Unlikely to comply with the study protocol or unable to return for follow-up visits.
- Diagnosis of other cancers (except prior pancreatic cancer or non-melanoma skin cancer) within 3 years before screening.
- Pregnant or nursing women, or women of childbearing potential not using contraception.
- Adults under legal protection.
- Not covered by health insurance.
- Unable to understand and sign informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Montpellier
Montpellier, Hérault, France, 34295
Actively Recruiting
Research Team
C
Catherine ALIX-PANABIERES, Ph.D
CONTACT
T
Thomas BARDOL, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here